US Patent Issued to Ukko on Feb. 17 for "De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity" (Israeli Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,844, issued on Feb. 17, was assigned to Ukko Inc. (San Francisco).

"De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity" was invented by Yanay Ofran (Tel Aviv, Israel), Moshe Ben-David (Rehovot, Israel), Assaf Biran (Tel-Aviv, Israel), Shiri Zakin (Sde Warburg, Israel), Orly Marcu Garber (Modi'in, Israel) and Anna Chuprin (Tel Aviv, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "A de-epitoped alpha gliadin is provided. Methods of generating same and uses thereof are also provided."

The patent was filed on July 2, 2020, under Application No. 17/624,600.

*For further information, including ima...